(S)-2-(3-Fluorophenyl)pyrrolidine hydrochloride, 97.0%, 1g

4,6-Dichloro-1H-pyrazolo[3,4-d]pyrimidine, 97.0%, 5g

tert-Butyl 4-((2-bromophenyl)amino)-4-cyanopiperidine-1-carboxylate, 95%, 100mg

6,6'-Dimethyl 5,5'-dibromo-2H,2'H,3H,3'H-[1,1'-biindole]-6,6'-dicarboxylate, 97%, 500mg

1,2-Dioleoyl-sn-glycero-3-phosphocholine, >99%, 250mg

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 100, 4000 ml, 250 mm, 1 Piece

2-Isobutyl-3-methoxypyrazine>97.0%(GC)(T)1mL

Glass syringe with Luer connection (glass), 20 ml, 1 piece

Thieno[3,2-b]pyridin-6-ol, 95.0%, 25mg

3-Chloro-6-methylpyrazine-2-carbonitrile, 95+%, 100mg

2,5-Bis(methylthio)-1,3,4-thiadiazole, 98%, 250mg

2,3-Dimethoxy-5-methyl-1,4-benzoquinone>97.0%(T)1g

4-Vinylcyclohex-1-ene (stabilised with BHT), 95.0%, 25ml